IntrinsicIntrinsic
← Scroll for more →

Financial Statements — GLNS

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.000.000.000.000.000.00-------------0.000.00--0.000.000.00
Total Assets0.010.000.010.010.000.010.010.000.010.010.000.000.00--0.000.010.000.01
Accounts Payable0.170.170.160.150.140.130.130.050.050.200.210.210.210.210.200.200.190.19
Total Liabilities0.940.920.910.880.860.840.810.800.790.770.750.750.710.700.690.660.650.65
Retained Earnings(1.04)(1.03)(1.01)(0.98)(0.96)(0.94)(0.91)(0.90)(0.89)(0.87)(0.85)(0.85)(0.81)(0.81)(0.79)(0.76)(0.76)(0.75)
Total Stockholder Equity(0.94)(0.92)(0.91)(0.87)(0.86)(0.83)(0.81)(0.80)(0.78)(0.76)(0.75)(0.74)(0.71)(0.70)(0.69)(0.66)(0.65)(0.64)
← Scroll for more columns →

Income Statement

(in thousands USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Total Operating Expenses13.1114.1415.6717.2317.6113.6723.4214.4312.7810.0011.3413.510.5812.2713.9119.4717.578.3113.2618.42
Net Income(13.11)(14.13)(15.66)(17.23)(17.60)(13.67)(23.42)(14.43)(12.78)(10.00)(11.33)(13.51)(0.58)(12.27)(13.91)(19.47)(17.57)(8.31)(13.26)(18.42)
Basic EPS--0.000.000.00(0.01)0.000.000.00(0.01)0.000.000.00(0.01)0.000.000.000.000.00----
Diluted EPS--0.000.000.00(0.01)0.000.000.00(0.01)0.000.000.00(0.01)--------------
← Scroll for more columns →

Cash Flow Statement

(in thousands USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Operating Cash Flow(3.73)(12.72)(4.07)(16.79)(5.09)(12.12)(13.84)(16.03)(3.51)(13.03)(3.65)(17.36)(88.21)(19.58)(1.20)(30.53)(9.36)(9.57)(0.01)(24.06)
Financing Cash Flow3.7412.724.0716.795.1312.1213.8516.023.5213.043.6617.3588.2319.581.2030.539.369.570.0123.97
← Scroll for more columns →